Literature DB >> 9041574

Therapeutic options for severe, refractory status asthmaticus: inhalational anaesthetic agents, extracorporeal membrane oxygenation and helium/oxygen ventilation.

J D Tobias1, J S Garrett.   

Abstract

Despite improvements in supportive care, the mortality and morbidity of asthma remain constant. The risks and incidence of morbidity related to barotrauma remain high in patients that require mechanical ventilation. The authors present three alternative strategies including the inhalation of anaesthetic agents, helium/ oxygen ventilation, and extracorporeal membrane oxygenation which may be beneficial when "conventional therapies' fail in the intubated patient with status asthmaticus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041574     DOI: 10.1046/j.1460-9592.1997.d01-33.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  5 in total

1.  Targeted Versus Continuous Delivery of Volatile Anesthetics During Cholinergic Bronchoconstriction.

Authors:  Jarred R Mondoñedo; John S McNeil; Jacob Herrmann; Brett A Simon; David W Kaczka
Journal:  J Eng Sci Med Diagn Ther       Date:  2018-05-09

2.  Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit.

Authors:  I Federico Fernandez Nievas; Kanwaljeet J S Anand
Journal:  J Pediatr Pharmacol Ther       Date:  2013-04

3.  Isoflurane therapy for severe refractory status asthmaticus in children.

Authors:  Venkat Shankar; Kevin B Churchwell; Jayant K Deshpande
Journal:  Intensive Care Med       Date:  2006-05-05       Impact factor: 17.440

4.  Volatile Anesthetics and the Treatment of Severe Bronchospasm: A Concept of Targeted Delivery.

Authors:  Jarred R Mondoñedo; John S McNeil; Samir D Amin; Jacob Herrmann; Brett A Simon; David W Kaczka
Journal:  Drug Discov Today Dis Models       Date:  2014-04-29

5.  Experience with use of extracorporeal life support for severe refractory status asthmaticus in children.

Authors:  Kiran B Hebbar; Toni Petrillo-Albarano; Wendy Coto-Puckett; Micheal Heard; Peter T Rycus; James D Fortenberry
Journal:  Crit Care       Date:  2009-03-02       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.